Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Philippe, Huot"'
Autor:
Michael P. Cooreman, Javed Butler, Robert P. Giugliano, Faiez Zannad, Lucile Dzen, Philippe Huot-Marchand, Martine Baudin, Daniel R. Beard, Jean-Louis Junien, Pierre Broqua, Manal F. Abdelmalek, Sven M. Francque
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Lanifibranor, a pan-PPAR agonist, improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH), who have poor cardiometabolic health (CMH) and cardiovascular events as major mortality cause. NATIVE trial
Externí odkaz:
https://doaj.org/article/a8349f7dd9df4b16ac7569db5e4e8c59
Autor:
Xinyu Ji, MD, CM, Ke Xuan Li, MD, CM, Leonardo Furtado Freitas, MD, EDiNR, Philippe Huot, MD, PhD, FRCPC, dABPN
Publikováno v:
Radiology Case Reports, Vol 19, Iss 1, Pp 126-129 (2024)
Metronidazole is a commonly used antibiotic with anaerobic bacterial, protozoal, and microaerophilic bacterial coverage. Encephalopathy and peripheral neurotoxicity are rare but known adverse events with prolonged metronidazole use, which can be diff
Externí odkaz:
https://doaj.org/article/637f4e2a40224440836dfed3569c8eb7
Autor:
Cécile Tissot, Andréa L. Benedet, Joseph Therriault, Tharick A. Pascoal, Firoza Z. Lussier, Paramita Saha-Chaudhuri, Mira Chamoun, Melissa Savard, Sulantha S. Mathotaarachchi, Gleb Bezgin, Yi-Ting Wang, Jaime Fernandez Arias, Juan Lantero Rodriguez, Anniina Snellman, Nicholas J. Ashton, Thomas K. Karikari, Kaj Blennow, Henrik Zetterberg, Etienne De Villers-Sidani, Philippe Huot, Serge Gauthier, Pedro Rosa-Neto, for the Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-11 (2021)
Abstract Background To investigate the association of plasma pTau181, assessed with a new immunoassay, with neurodegeneration of white matter and gray matter cross-sectionally and longitudinally, in aging and Alzheimer’s disease. Methods Observatio
Externí odkaz:
https://doaj.org/article/b8875842eed84995a8984129174cefb7
Autor:
Imane Frouni, Dominique Bédard, Élodie Bourgeois-Cayer, Adjia Hamadjida, Fleur Gaudette, Francis Beaudry, Philippe Huot
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 396:1053-1060
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a5ae91d6bb8155162dca0130cd322c5
https://doi.org/10.1007/s00210-022-02378-1
https://doi.org/10.1007/s00210-022-02378-1
Autor:
Bernard Combe, Rene-Marc Flipo, Alain Saraux, Francis Fagnani, Jacques Massol, Gabrielle Cukierman, Jean-Michel Joubert, Philippe Huot-Marchand
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Objective To evaluate the performance of clinical criteria for predicting late treatment failure in patients with early non-response to certolizumab pegol (CZP).Methods A protocol-specified analysis of interim data from ECLAIR, a 3-year longitudinal,
Externí odkaz:
https://doaj.org/article/a7c0fd1c17fd440db3df7951cfa3bfb5
Autor:
Imane Frouni, Philippe Huot
Publikováno v:
Neurodegenerative Disease Management. 12:203-214
Levodopa is the standard treatment for Parkinson’s disease, but its use is marred by the emergence of dyskinesia, for which treatment options remain limited. Here, we review the glutamatergic modulators that were assessed for their antidyskinetic p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f7f02666702297a103921c8dca3ed9
https://doi.org/10.2217/nmt-2021-0055
https://doi.org/10.2217/nmt-2021-0055
Publikováno v:
Pharmacological Reports. 74:614-625
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19336e0fdd820c5ec5ab1ea36b8f49fb
https://doi.org/10.1007/s43440-022-00378-9
https://doi.org/10.1007/s43440-022-00378-9
Publikováno v:
Neurodegenerative Disease Management.
Levodopa is the most effective agent for treating the symptoms of Parkinson's disease (PD). However, levodopa-induced dyskinesia remains a significant complication that manifests after few years of treatment, for which therapeutic options remain limi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d969193f6aa3adc6b315d16d7410529
https://doi.org/10.2217/nmt-2022-0039
https://doi.org/10.2217/nmt-2022-0039
Autor:
Min Su Kang, Adjia Hamadjida, Dominique Bédard, Stephen G. Nuara, Jim C. Gourdon, Stephen Frey, Arturo Aliaga, Karen Ross, Robert Hopewell, Hussein Bdair, Axel Mathieu, Christine Lucas Tardif, Jean-Paul Soucy, Gassan Massarweh, Pedro Rosa-Neto, Philippe Huot
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7af34356d1f45332784ca1870ecc3dd7
https://doi.org/10.1007/s00210-023-02458-w
https://doi.org/10.1007/s00210-023-02458-w
Autor:
Cynthia Kwan, Catherine Lévesque, Dominique Bédard, Imane Frouni, Jemal M Yesuf, Adjia Hamadjida, Daniel Lévesque, Paul BS Clarke, Philippe Huot
Publikováno v:
Neuroscience Research. 177:135-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d3d04fa9427a3d28dabcfe945fc1df
https://doi.org/10.1016/j.neures.2021.12.004
https://doi.org/10.1016/j.neures.2021.12.004